meds: the income statement

MyFinsight

For the quarter ending 2024-06-30, MEDS made $18,699 in revenue. -$1,833,902 in net income. Net profit margin of -9807.49%.

Unit: Dollar

Income Statement	2024-06-30
Revenue	18,699
Cost of sales	19,402
Gross profit	-703
General and administrative	415,421
Technology expense	86,674
Accounting and legal expense	171,708
Professional fees	509,136
Wage and salary expense	312,049
Operating expenses	1,494,988
Operating income (loss)	-1,495,691
Interest expense, nonoperating	4,949
Interest income	41,031
Change in fair value of warrant liability	-165,132
Nonoperating income (expense)	-129,050
Net loss from continuing operations	-1,624,741
Net (loss) income on discontinued operations	-209,161
Net income (loss)	-1,833,902

Basic eps	-1.3
Diluted eps	-1.3
Basic average shares	1,406,348
Diluted average shares	1,406,348